113 related articles for article (PubMed ID: 455584)
1. Vindesine as a single agent in the treatment of advanced malignant melanoma.
Retsas S; Newton KA; Westbury G
Cancer Chemother Pharmacol; 1979; 2(4):257-60. PubMed ID: 455584
[TBL] [Abstract][Full Text] [Related]
2. A multicentre phase II trial of vindesine in malignant melanoma.
Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
[TBL] [Abstract][Full Text] [Related]
3. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
[TBL] [Abstract][Full Text] [Related]
4. Vindesine in the treatment of breast cancer.
Smith IE; Powles TJ
Cancer Chemother Pharmacol; 1979; 2(4):261-2. PubMed ID: 455585
[TBL] [Abstract][Full Text] [Related]
5. Vindesine for metastatic malignant melanoma. A phase II trial.
Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
[TBL] [Abstract][Full Text] [Related]
6. Update results of vindesine as a single agent in the therapy of advanced malignant melanoma.
Retsas S; Peat I; Ashford R; Coe M; Maher J; Drury A; Hanham IW; Phillips RH; Newton KA; Westbury G
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():87-90. PubMed ID: 7438128
[No Abstract] [Full Text] [Related]
7. Phase II study of vindesine in metastatic malignant melanoma.
Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
[No Abstract] [Full Text] [Related]
8. Phase II trial of vindesine in patients with malignant melanoma.
Camacho FJ; Young CW; Wittes RE
Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
[No Abstract] [Full Text] [Related]
9. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
Sordillo PP; Magill GB; Gralla RJ
Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
[No Abstract] [Full Text] [Related]
10. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
[No Abstract] [Full Text] [Related]
11. Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.
Mulder JH; Dodion P; Cavalli F; Czarnetzki B; Clavel M; Thomas D; Suciu S; Rozencweig M
Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1297-301. PubMed ID: 6891928
[TBL] [Abstract][Full Text] [Related]
12. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A
Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238
[TBL] [Abstract][Full Text] [Related]
13. Vindesine. A review of phase-II trials.
Gralla RJ; Tan CT; Young CW
Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587
[TBL] [Abstract][Full Text] [Related]
14. Phase I anti-cancer agents: vindesine (desacetyl vinblastine amide sulfate).
Dyke RW; Nelson RL
Cancer Treat Rev; 1977 Jun; 4(2):135-42. PubMed ID: 329987
[No Abstract] [Full Text] [Related]
15. Broad phase II study of vindesine.
Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
[TBL] [Abstract][Full Text] [Related]
16. Vindesine in the treatment of metastatic breast cancer.
Hansen PV; Brincker H
Eur J Cancer Clin Oncol; 1984 Oct; 20(10):1221-5. PubMed ID: 6541581
[TBL] [Abstract][Full Text] [Related]
17. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
Retsas S; Thomas C; Hobbs JR
Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
[No Abstract] [Full Text] [Related]
18. An EORTC phase II study of vindesine in advanced prostate cancer.
Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology, clinical efficacy and adverse effects of vindesine sulfate, a new vinca alkaloid.
Cersosimo RJ; Bromer R; Licciardello JT; Hong WK
Pharmacotherapy; 1983; 3(5):259-74. PubMed ID: 6359081
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of vindesine in advanced neoplastic disease.
Stambaugh JE
Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
[No Abstract] [Full Text] [Related]
[Next] [New Search]
